Related Experiment Video
Updated: May 26, 2026

13:20
Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Chk2 mediates RITA-induced apoptosis
J de Lange1, M Verlaan-de Vries, A F A S Teunisse
1Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
Cell Death and Differentiation
|December 14, 2011
Summary
Reactivation of p53 tumor-suppressor protein using RITA triggers apoptosis. This study reveals that Chk2 kinase is essential for RITA
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Reactivating the p53 tumor-suppressor protein is a key cancer therapy strategy.
- Small molecules like RITA (reactivation of p53 and induction of tumor cell apoptosis) show promise.
- The precise molecular mechanisms of RITA's action are not fully understood.
Purpose of the Study:
- To investigate the role of Chk2 kinase in cellular responses to RITA.
- To elucidate the contribution of Chk2 to RITA-induced apoptosis and DNA damage response.
- To understand the interplay between p53 transcriptional activity and Chk2 in RITA treatment.
Main Methods:
- Utilized RITA and Nutlin-3 treatments in cancer cell models.
- Assessed apoptosis induction, Chk2 phosphorylation, and p53 transcriptional activity.
- Investigated DNA replication block and DNA damage response.
- Employed knockdown strategies for Noxa and p53.
Main Results:
- RITA-induced apoptosis is critically dependent on Chk2 kinase.
- p53 transcriptional activity in response to RITA requires Chk2.
- An early p53- and Chk2-dependent block in DNA replication was observed.
- RITA-induced DNA damage response is significantly reduced in cells lacking p53 or Chk2.
Conclusions:
- Chk2 is an essential mediator of cellular responses to RITA.
- Chk2 plays a crucial role in RITA-driven apoptosis and DNA damage signaling.
- Targeting Chk2 may enhance the efficacy of RITA-based cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
